SSI SCHAEFER's Four-Way Pallet Roaming Shuttle Is Expanding Warehouse Design Possibilities
SEOUL, South Korea, Oct. 26, 2026 /PRNewswire/ -- For warehouse operators in South Korea, warehouse design is increasingly shaped by competing demands: making better use of available space, managing labor constraints and maintaining reliable...
Syfe Launches Yield+ in Hong Kong to Make Locals' Savings Work Harder
The new HKD portfolio is designed for money set aside for 12 months or more, with no lock-in and no minimum investment HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Syfe, the Singapore-headquartered digital wealth platform managing over US$15 billion in...
Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Ailytics, a vision AI startup that turns existing industrial CCTV into a real-time safety and operations layer, has raised US$7.4 million in a Series A led by Tin Men Capital. SEEDS, part of SG Growth...
Results of CARsgen's Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026
SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the preliminary positive research results of the...
Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity
- ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models. - ASC39 demonstrated eloralintide-like selectivity for human amylin 1 receptor (hAMY1R) over...
Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026
SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein
The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its potential clinical value across treatment settings. SAN...
From Vietnam National Brand to Regional Giant: SUNHOUSE Secures Second Consecutive APEA Corporate Excellence Award
HANOI, Vietnam, Oct. 26, 2026 /PRNewswire/ -- At the Asia Pacific Enterprise Awards (APEA) 2026, SUNHOUSE was once again honored with the Asia Corporate Excellence Award. Marking its second consecutive victory, SUNHOUSE stands as the sole...